Literature DB >> 22496218

Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection.

Christina F Thobakgale1, Lena Fadda, Kimberly Lane, Ildiko Toth, Florencia Pereyra, Suzane Bazner, Thumbi Ndung'u, Bruce D Walker, Eric S Rosenberg, Galit Alter, Mary Carrington, Todd M Allen, Marcus Altfeld.   

Abstract

Natural killer (NK) cells play a critical role in the control of HIV-1 infection, and NK cells that respond to HIV-1 peptides have been recently described. However, the mechanisms by which NK cells recognize HIV-1 antigens are not fully understood. We investigated NK cell activation in response to HIV-1 peptides during early and chronic HIV-1 clade B infection using a whole-blood assay and multiparameter flow cytometry. Antibody-mediated NK cell activation in response to HIV-1 peptides was not detected in HIV-1-uninfected individuals. In contrast, 79% of individuals with chronic infection and 22% of individuals with early infection had detectable gamma interferon (IFN-γ) NK cell responses to HIV-1 antigens (P < 0.00001). IFN-γ- and tumor necrosis factor alpha (TNF-α)-producing NK cells most frequently targeted Env gp120 (median of 4% and range of 0 to 31% of all NK cells). NK cells rarely targeted other HIV-1 proteins such as Gag, Pol, and Nef. Antibody-mediated NK cell responses to peptides mapped predominantly to Env protein, required the presence of plasma or plasma IgG, and resulted in lower CD16 expression on NK cells, suggesting an antibody-mediated activation of NK cells. Further studies are needed to assess the consequences of these antibody-mediated NK cell responses for HIV-1 disease progression and vaccine-induced protection from infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496218      PMCID: PMC3393568          DOI: 10.1128/JVI.00569-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  NK cell recognition.

Authors:  Lewis L Lanier
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

2.  Licensing of natural killer cells by host major histocompatibility complex class I molecules.

Authors:  Sungjin Kim; Jennifer Poursine-Laurent; Steven M Truscott; Lonnie Lybarger; Yun-Jeong Song; Liping Yang; Anthony R French; John B Sunwoo; Suzanne Lemieux; Ted H Hansen; Wayne M Yokoyama
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

3.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

Authors:  Photini Kiepiela; Alasdair J Leslie; Isobella Honeyborne; Danni Ramduth; Christina Thobakgale; Senica Chetty; Prinisha Rathnavalu; Corey Moore; Katja J Pfafferott; Louise Hilton; Peter Zimbwa; Sarah Moore; Todd Allen; Christian Brander; Marylyn M Addo; Marcus Altfeld; Ian James; Simon Mallal; Michael Bunce; Linda D Barber; James Szinger; Cheryl Day; Paul Klenerman; James Mullins; Bette Korber; Hoosen M Coovadia; Bruce D Walker; Philip J R Goulder
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

4.  HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.

Authors:  Matthew S Parsons; Leia Wren; Gamze Isitman; Marjon Navis; Ivan Stratov; Nicole F Bernard; Stephen J Kent
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

5.  CD107a as a functional marker for the identification of natural killer cell activity.

Authors:  Galit Alter; Jessica M Malenfant; Marcus Altfeld
Journal:  J Immunol Methods       Date:  2004-11       Impact factor: 2.303

Review 6.  NK cells in HIV infection: paradigm for protection or targets for ambush.

Authors:  Anthony S Fauci; Domenico Mavilio; Shyam Kottilil
Journal:  Nat Rev Immunol       Date:  2005-11       Impact factor: 53.106

7.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Authors:  Domenico Mavilio; Gabriella Lombardo; Janet Benjamin; Diana Kim; Dean Follman; Emanuela Marcenaro; M Angeline O'Shea; Audrey Kinter; Colin Kovacs; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

8.  Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients.

Authors:  Manuela Fogli; Paola Costa; Giuseppe Murdaca; Maurizio Setti; Maria Cristina Mingari; Lorenzo Moretta; Alessandro Moretta; Andrea De Maria
Journal:  Eur J Immunol       Date:  2004-08       Impact factor: 5.532

9.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

10.  Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Authors:  M M Addo; X G Yu; A Rathod; D Cohen; R L Eldridge; D Strick; M N Johnston; C Corcoran; A G Wurcel; C A Fitzpatrick; M E Feeney; W R Rodriguez; N Basgoz; R Draenert; David R Stone; C Brander; P J R Goulder; E S Rosenberg; M Altfeld; B D Walker
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  13 in total

1.  Differential Effect of Mucosal NKp44+ Innate Lymphoid Cells and Δγ Cells on Simian Immunodeficiency Virus Infection Outcome in Rhesus Macaques.

Authors:  Mohammad Arif Rahman; Eun-Ju Ko; Gospel Enyindah-Asonye; Sabrina Helmold Hait; Christopher Hogge; Ruth Hunegnaw; David J Venzon; Tanya Hoang; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

2.  Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells.

Authors:  Henri-Alexandre Michaud; Devi SenGupta; Miguel de Mulder; Steven G Deeks; Jeffrey N Martin; James J Kobie; Jonah B Sacha; Douglas F Nixon
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

3.  Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes.

Authors:  Vijaya Madhavi; Marjon Navis; Amy W Chung; Gamze Isitman; Leia H Wren; Robert De Rose; Stephen J Kent; Ivan Stratov
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

4.  Phenotypic and Functional Characterization of Circulatory, Splenic, and Hepatic NK Cells in Simian Immunodeficiency Virus-Controlling Macaques.

Authors:  Diego A Vargas-Inchaustegui; Sabrina Helmold Hait; Hye Kyung Chung; Jigna Narola; Tanya Hoang; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

Review 5.  Natural killer cells in HIV-1 infection and therapy.

Authors:  Joanna Mikulak; Ferdinando Oriolo; Elisa Zaghi; Clara Di Vito; Domenico Mavilio
Journal:  AIDS       Date:  2017-11-13       Impact factor: 4.177

Review 6.  Immunogenetics of small ruminant lentiviral infections.

Authors:  Nancy Stonos; Sarah K Wootton; Niel Karrow
Journal:  Viruses       Date:  2014-08-22       Impact factor: 5.048

7.  Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort.

Authors:  Elizabeth Fink; Katherine Fuller; Brian Agan; Edward A Berger; Andrew Saphire; Gerald V Quinnan; John H Elder
Journal:  AIDS Res Hum Retroviruses       Date:  2016-11-21       Impact factor: 2.205

8.  Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates.

Authors:  María Julia Ruiz; Jimena Salido; Lorena Abusamra; Yanina Ghiglione; Cintia Cevallos; Gabriel Damilano; Ana María Rodriguez; César Trifone; Natalia Laufer; Luis D Giavedoni; Omar Sued; Horacio Salomón; María Magdalena Gherardi; Gabriela Turk
Journal:  EBioMedicine       Date:  2017-11-03       Impact factor: 8.143

9.  Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity.

Authors:  María Julia Ruiz; Yanina Ghiglione; Juliana Falivene; Natalia Laufer; María Pía Holgado; María Eugenia Socías; Pedro Cahn; Omar Sued; Luis Giavedoni; Horacio Salomón; María Magdalena Gherardi; Ana María Rodríguez; Gabriela Turk
Journal:  J Virol       Date:  2016-01-15       Impact factor: 5.103

Review 10.  Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.

Authors:  Martyn A French; M Christian Tjiam; Laila N Abudulai; Sonia Fernandez
Journal:  Front Immunol       Date:  2017-07-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.